Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.205 USD | +1.42% | -18.77% | -17.71% |
Apr. 04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
Apr. 04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.71% | 190M | |
-1.82% | 41.35B | |
+42.15% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
-3.74% | 11.68B | |
+22.12% | 11.6B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- ABOS Stock
- News Acumen Pharmaceuticals, Inc.
- Acumen Pharmaceuticals : Stifel Initiates Acumen Pharmaceuticals at Buy Rating With $27 Price Target